Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgery. Issue 1 (25th October 2021)

• Record Type: Journal Article
• Authors: Chen, Xuguang; Parekh, Vishwa S; Peng, Luke; Chan, Michael D; Redmond, Kristin J; Soike, Michael; McTyre, Emory; Lin, Doris; Jacobs, Michael A; Kleinberg, Lawrence R
• Is Part Of: Neuro-oncology advances. Volume 3:Issue 1(2021)
• Publication Date: 2021-10-25
• Subjects: brain metastasis -- machine learning -- magnetic resonance imaging -- multiparametric radiomics -- radiation necrosis; 616.99481
• DOI: 10.1093/noajnl/vdab150
• Languages: English
• ISSNs: 2632-2498

Abstract

Abstract: Background: Stereotactic radiosurgery (SRS) may cause radiation necrosis (RN) that is difficult to distinguish from tumor progression (TP) by conventional MRI. We hypothesize that MRI-based multiparametric radiomics (mpRad) and machine learning (ML) can differentiate TP from RN in a multi-institutional cohort. Methods: Patients with growing brain metastases after SRS at 2 institutions underwent surgery, and RN or TP were confirmed by histopathology. A radiomic tissue signature (RTS) was selected from mpRad, as well as single T1 post-contrast (T1 c) and T2 fluid-attenuated inversion recovery (T2 -FLAIR) radiomic features. Feature selection and supervised ML were performed in a randomly selected training cohort ( N = 95) and validated in the remaining cases ( N = 40) using surgical pathology as the gold standard. Results: One hundred and thirty-five discrete lesions (37 RN, 98 TP) from 109 patients were included. Radiographic diagnoses by an experienced neuroradiologist were concordant with histopathology in 67% of cases (sensitivity 69%, specificity 59% for TP). Radiomic analysis indicated institutional origin as a significant confounding factor for diagnosis. A random forest model incorporating 1 mpRad, 4 T1 c, and 4 T2 -FLAIR features had an AUC of 0.77 (95% confidence interval [CI]: 0.66–0.88), sensitivity of 67% and specificity of 86% in the training cohort, and AUC of 0.71 (95% CI: 0.51–0.91), sensitivity of 52% and specificity of 90% in the validation cohort. Conclusions: MRI-based mpRad and ML can distinguish TP from RN with high specificity, which may facilitate the triage of patients with growing brain metastases after SRS for repeat radiation versus surgical intervention.